ATE553092T1 - Indazolderivate - Google Patents

Indazolderivate

Info

Publication number
ATE553092T1
ATE553092T1 AT04771301T AT04771301T ATE553092T1 AT E553092 T1 ATE553092 T1 AT E553092T1 AT 04771301 T AT04771301 T AT 04771301T AT 04771301 T AT04771301 T AT 04771301T AT E553092 T1 ATE553092 T1 AT E553092T1
Authority
AT
Austria
Prior art keywords
substituted
unsubstituted
heterocyclic group
hydrogen atom
ararkyl
Prior art date
Application number
AT04771301T
Other languages
English (en)
Inventor
Yoshihisa Ohta
Fumihiko Kanai
Shinji Nara
Yutaka Kanda
Hiroshi Umehara
Yukimasa Shiotsu
Tomoki Naoe
Hitoshi Kiyoi
Keiko Kawashima
Hiromi Ando
Motoki Miyama
Original Assignee
Kyowa Hakko Kirin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kirin Co Ltd filed Critical Kyowa Hakko Kirin Co Ltd
Application granted granted Critical
Publication of ATE553092T1 publication Critical patent/ATE553092T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT04771301T 2003-07-30 2004-07-30 Indazolderivate ATE553092T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003203508 2003-07-30
PCT/JP2004/011287 WO2005012257A1 (ja) 2003-07-30 2004-07-30 インダゾール誘導体

Publications (1)

Publication Number Publication Date
ATE553092T1 true ATE553092T1 (de) 2012-04-15

Family

ID=34113614

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04771301T ATE553092T1 (de) 2003-07-30 2004-07-30 Indazolderivate

Country Status (15)

Country Link
US (2) US7470717B2 (de)
EP (1) EP1652842B1 (de)
JP (1) JP4335212B2 (de)
KR (1) KR20060119705A (de)
CN (1) CN100390149C (de)
AT (1) ATE553092T1 (de)
AU (1) AU2004260756B2 (de)
BR (1) BRPI0408876A (de)
CA (1) CA2518950A1 (de)
EA (1) EA010165B1 (de)
ES (1) ES2384568T3 (de)
MX (1) MXPA05011420A (de)
NO (1) NO20055333L (de)
WO (1) WO2005012257A1 (de)
ZA (1) ZA200509952B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140390A (en) 2002-03-13 2009-12-31 Janssen Pharmaceutica Nv Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
ES2347544T3 (es) 2002-03-13 2010-11-02 Janssen Pharmaceutica Nv Inhibidores de histona-desacetilasas.
BR0307607A (pt) 2002-03-13 2004-12-21 Janssen Pharmaceutica Nv Derivados de carbonilamino como inibidores de histona desacetilase
NZ534833A (en) 2002-03-13 2006-07-28 Janssen Pharmaceutica Nv Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase (HDAC)
ATE553092T1 (de) * 2003-07-30 2012-04-15 Kyowa Hakko Kirin Co Ltd Indazolderivate
BRPI0512676B8 (pt) 2004-07-28 2021-05-25 Janssen Pharmaceutica Nv derivados de indolil alquil amina substituídos como inibidores de histona desacetilase, composição farmacêutica que os compreende, seus processos de preparação e uso
WO2006080450A1 (ja) * 2005-01-27 2006-08-03 Kyowa Hakko Kogyo Co., Ltd. Igf-1r阻害剤
EP1878737A4 (de) * 2005-04-28 2010-08-04 Kyowa Hakko Kirin Co Ltd Verfahren zur herstellung von indazol-3-ylmethylphosphoniumsalz
EP1885710B1 (de) 2005-05-18 2015-08-19 Janssen Pharmaceutica N.V. Substituierte aminopropenylpiperidin- oder morpholinderivate als neue histondeacetylase-hemmer
WO2007048767A1 (en) * 2005-10-27 2007-05-03 Janssen Pharmaceutica N.V. Squaric acid derivatives as inhibitors of histone deacetylase
CA2631874C (en) 2006-01-19 2014-11-18 Janssen Pharmaceutica N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
JP5225104B2 (ja) 2006-01-19 2013-07-03 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 新しい、ヒストンデアセチラーゼのインヒビターとしてのアミノフェニル誘導体
EP1979326B1 (de) 2006-01-19 2012-10-03 Janssen Pharmaceutica N.V. Pyridin- und pyrimidinderivate als inhibitoren von histondeacetylase
ES2481408T3 (es) 2006-01-19 2014-07-30 Janssen Pharmaceutica, N.V. Derivados sustituidos de indolilalquilaminas como inhibidores de histona-desacetilasas
EP2036894A4 (de) * 2006-06-30 2011-01-12 Kyowa Hakko Kirin Co Ltd Aurora-inhibitor
WO2008001885A1 (en) 2006-06-30 2008-01-03 Kyowa Hakko Kirin Co., Ltd. Abl KINASE INHIBITOR
JPWO2008020606A1 (ja) * 2006-08-16 2010-01-07 協和発酵キリン株式会社 血管新生阻害剤
GB0619325D0 (en) 2006-09-30 2006-11-08 Univ Strathclyde New compounds
CN101641117B (zh) 2007-03-05 2012-06-13 协和发酵麒麟株式会社 药物组合物
US20100104567A1 (en) 2007-03-05 2010-04-29 Kyowa Hakko Kirin Co., Ltd. Pharmaceutical composition
WO2008114812A1 (ja) * 2007-03-19 2008-09-25 Kyowa Hakko Kirin Co., Ltd. Jak阻害剤
US20090325964A1 (en) * 2008-05-23 2009-12-31 Wyeth Piperazine Metabotropic Glutamate Receptor 5 (MGLUR5) Negative Allosteric Modulators For Anxiety/Depression
CN103804382A (zh) * 2012-11-05 2014-05-21 韩文毅 一类治疗湿疹的化合物及其用途
CN103804306A (zh) * 2012-11-12 2014-05-21 韩文毅 一类治疗糖尿病的化合物及其用途
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy
EA037327B1 (ru) 2015-09-22 2021-03-12 Грейбуг Вижн, Инк. Соединения и композиции для лечения глазных расстройств
EP3600324A4 (de) 2017-03-23 2020-12-09 Graybug Vision, Inc. Arzneimittel und zusammensetzungen zur behandlung von augenkrankheiten
US11160870B2 (en) 2017-05-10 2021-11-02 Graybug Vision, Inc. Extended release microparticles and suspensions thereof for medical therapy
US11629139B2 (en) 2017-09-08 2023-04-18 President And Fellows Of Harvard College Small molecule inhibitors of Ebola and Lassa fever viruses and methods of use
JP7434274B2 (ja) * 2018-07-23 2024-02-20 セルジーン・クオンティセル・リサーチ・インコーポレイテッド ブロモドメイン阻害剤の合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0232059A (ja) 1988-07-18 1990-02-01 Kyowa Hakko Kogyo Co Ltd インダゾール誘導体
PE20010306A1 (es) 1999-07-02 2001-03-29 Agouron Pharma Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
TWI262914B (en) * 1999-07-02 2006-10-01 Agouron Pharma Compounds and pharmaceutical compositions for inhibiting protein kinases
US6632815B2 (en) 1999-09-17 2003-10-14 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
YU54202A (sh) 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
US7238853B2 (en) 2000-07-14 2007-07-03 Unicrop Ltd Molecular mechanisms for gene containment in plants
US7211594B2 (en) 2000-07-31 2007-05-01 Signal Pharmaceuticals, Llc Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith
US6897231B2 (en) 2000-07-31 2005-05-24 Signal Pharmaceuticals, Inc. Indazole derivatives as JNK inhibitors and compositions and methods related thereto
US20050009876A1 (en) 2000-07-31 2005-01-13 Bhagwat Shripad S. Indazole compounds, compositions thereof and methods of treatment therewith
CA2440842A1 (en) 2001-04-16 2002-10-24 Eisai Co., Ltd. Novel 1h-indazole compounds
CN1656079A (zh) 2002-05-31 2005-08-17 卫材株式会社 吡唑化合物和含有该化合物的药物组合物
US20060058366A1 (en) 2002-12-03 2006-03-16 Kyowa Hakko Kogyo Co., Ltd. Jnk inhibitor
ATE553092T1 (de) * 2003-07-30 2012-04-15 Kyowa Hakko Kirin Co Ltd Indazolderivate

Also Published As

Publication number Publication date
EP1652842A4 (de) 2008-10-01
EA010165B1 (ru) 2008-06-30
US7470717B2 (en) 2008-12-30
BRPI0408876A (pt) 2006-04-11
US20070117856A1 (en) 2007-05-24
JP4335212B2 (ja) 2009-09-30
JPWO2005012257A1 (ja) 2006-09-14
EA200600333A1 (ru) 2006-06-30
ES2384568T3 (es) 2012-07-09
US20090082348A1 (en) 2009-03-26
EP1652842A1 (de) 2006-05-03
US7919517B2 (en) 2011-04-05
KR20060119705A (ko) 2006-11-24
MXPA05011420A (es) 2005-12-12
WO2005012257A1 (ja) 2005-02-10
NO20055333L (no) 2005-11-11
ZA200509952B (en) 2006-09-27
EP1652842B1 (de) 2012-04-11
CN1777590A (zh) 2006-05-24
AU2004260756A1 (en) 2005-02-10
AU2004260756B2 (en) 2010-03-25
CN100390149C (zh) 2008-05-28
CA2518950A1 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
ATE553092T1 (de) Indazolderivate
CY1117132T1 (el) Παραγωγο θειαζολιου
AP1902A (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
NO20060219L (no) Forbindelser
CY1112899T1 (el) Παραγωγα θειαδιαζολινης για τη θεραπεια του καρκινου
FR15C0027I2 (fr) Derives de pyrazolinone
NO20072753L (no) 3-Etylidenhydrazinosubstituerte heterocykliske forbindelser som trombopoietinreseptoraktivatorer
TW200722422A (en) Heterocyclic compound and organic electroluminescent device using the same
NO20075734L (no) Tiofenforbindelser og trombopoietin reseptoractivatorer
DK1643984T3 (da) Anvendelse af parthenolidderivater som antileukæmiske og cytotoksske midler
DE69813605D1 (de) Benzofuranderivate
GB0423405D0 (en) Organic compounds
ATE282605T1 (de) 2-thio-subsituierte imidazolderivative und ihre verwendung in der pharmazie
TW200613297A (en) Pyrazole derivatives
ATE246174T1 (de) Tosylprolin-derivate als thymidylat-synthase inhibitoren
ATE261938T1 (de) Benzolsulfonamid-derivate und ihre verwendung
ATE552003T1 (de) Chinoxalinderivate
ATE448198T1 (de) Neue alpha-ketoamidderivate und deren verwendung
DE60211018D1 (de) Fungizide thiazolderivate
DE60103732D1 (de) Pyrimidinderivate mit antitumor-wirkung
ATE261962T1 (de) Benzonaphtyridin-1,8 derivate
UA89970C2 (ru) Гетероциклические соединения и активаторы рецептора тромбопоэтина
TH79781A (th) อนุพันธ์ไพราโซล